Switch to:
More From Other Websites
Biotech: In Unfamiliar Territory? Aug 31 2016
BioMarin to Attend Upcoming Investor Conferences Aug 31 2016
BioMarin to Attend Upcoming Investor Conferences Aug 31 2016
3 Biotech Stocks Could Be the Next Big Takeover Targets Aug 31 2016
What Do Analysts Think about BioMarin’s Return Potential? Aug 26 2016
What Should We Expect from BioMarin’s Kuvan in 2016? Aug 26 2016
How Much Did BioMarin’s Lead Drug Vimizim Earn in 1H16? Aug 26 2016
What’s BioMarin’s Expected Revenue Growth in 2016 and 2017? Aug 25 2016
Why Roche Might Be Interested in BioMarin Aug 25 2016
BioMarin’s Valuation on a Price-to-Sales Basis: Does It Matter? Aug 25 2016
Biotech Stocks: Oops, She Did It Again Aug 25 2016
[$$] Smaller Biotech Buyout Targets After Medivation Aug 24 2016
Forbes Ranks BioMarin 10th Most Innovative Company in the World Aug 24 2016
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss Aug 23 2016
The $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation Aug 22 2016
Biotech's next big deal? Aug 22 2016
Betting on BioMarin Aug 22 2016
Biotechs Rise on Bet Medivation Losers Will Look to Next Deal Aug 22 2016
BioMarin (BMRN) Stock Surges on Takeover Speculation Aug 22 2016
Break Up Gilead Sciences? Not So Fast Aug 19 2016
Why You Shouldn't Bet Against BioMarin Pharmaceutical (BMRN) Stock Aug 16 2016
The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen Aug 12 2016
BioMarin Announces Pricing of Public Offering of Common Stock Aug 09 2016
BioMarin Announces Public Offering of Common Stock Aug 08 2016
BioMarin reports 2Q loss Aug 04 2016
BioMarin Announces Second Quarter 2016 Financial Results Aug 04 2016
FDA Accepts BLA for BioMarin's Cerliponase Alfa for CLN2 Disease, Form of Batten Disease Jul 27 2016
BioMarin Provides Positive Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A in Late... Jul 27 2016
Buyout target Medivation says cancer drug could be 'best in class' Jul 06 2016
BioMarin Announces Acceptance of Late Breaking Abstract for BMN 270 at the World Federation of... Jun 20 2016
BioMarin Announces Withdrawal of Market Authorization Application for Kyndrisa™ (drisapersen) in... Jun 01 2016
BioMarin to Attend Upcoming Investor Conferences May 04 2016
BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment... May 03 2016
BioMarin reports 1Q loss Apr 28 2016
BioMarin Announces First Quarter 2016 Financial Results Apr 28 2016
BioMarin Enrolls First Patient in Phase 1/2 Trial of NAGLU Fusion Protein BMN 250 for Treatment of... Apr 21 2016
BioMarin Provides Program Update on Vosoritide in Achondroplasia Apr 20 2016
BioMarin Provides Encouraging Preliminary Data on First 8 Patients in Hemophilia A Gene Therapy... Apr 20 2016
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) to Ring The Nasdaq Stock Market Closing Bell Apr 18 2016
BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on April 20th in New... Apr 18 2016
BioMarin to Host First Quarter 2016 Financial Results Conference Call and Webcast on Thursday, April... Apr 12 2016
US close: Stocks gain after FOMC meeting minutes Apr 07 2016
BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor... Mar 24 2016
BioMarin Phase 3 Study of Pegvaliase for Phenylketonuria (PKU) Meets Primary Endpoint of Blood... Mar 21 2016
US close: Wall Street finishes on mixed note Feb 29 2016
BioMarin misses 4Q profit forecasts Feb 25 2016
US close: Stocks slip as oil futures come under pressure Feb 19 2016
BioMarin to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call and Webcast on... Jan 28 2016
BioMarin reports 3Q loss Oct 29 2015
Nasdaq powers to new all-time high Jun 18 2015
Study for treatment for dwarfism send BioMarin stock skyward Jun 18 2015
BioMarin reports 1Q loss Apr 30 2015
BioMarin reports 4Q loss Feb 25 2015
US STOCKS-S&P 500 ticks up to record on central bank bets Nov 24 2014
US STOCKS-Wall St up on central bank bets, deals support Nov 24 2014
US STOCKS-Wall St hits new records, but telecom weighs on Dow Nov 24 2014
US STOCKS-Wall St hits new records, boosted by cyclicals Nov 24 2014
US STOCKS-Wall St surges to new records, boosted by cyclicals Nov 24 2014
US STOCKS-Futures point to higher open on merger activity Nov 24 2014
US STOCKS-Futures rise, boosted by merger activity Nov 24 2014
BioMarin Pharma offers about $680M for Prosensa Nov 24 2014
US STOCKS-Futures higher, building on recent gains Nov 24 2014
BioMarin beats 3Q profit forecasts Oct 23 2014
Roche's $8 billion InterMune buy not a signal for more big deals Sep 16 2014
Early data suggest Sanofi, Regeneron drug may halve heart risk Aug 31 2014
Roche to buy U.S. biotech firm InterMune for $8.3 billion Aug 25 2014
Roche to buy U.S. biotech firm InterMune for $8.3 bln Aug 25 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK